DRUG RECALL LAWYER BLOG ROUND-UP
March 9, 2010 by admin
Filed under Drugs Attorney
Time to arise up as well as face a week! Here have been a stories we’re following:
- Avandia: The U.K.’s Guardian blogs about GlaxoSmithKline’s intensity $6 billion liability. @TomLamb as well as we have been skeptical.
- Vioxx: Australian decider finds for plaintiff in poor drug legal case opposite Merck, yet manners which Merck was not negligent. (HT: Pharmalot). Merck’s press recover is here.
- FDA: The FDA is starting to step up criminal prosecutions of corporate officials.
- Insulin Pump Defects: Insulin pumps have been raid by problems, travelling opposite a spectrum of manufacturers (HT: Drug Injury Lawyer Blog).
- 510k Approvals in February: See a list here.
- Direct-to-Consumer Advertising: BigPharma’s DTC promotion increasing by a “paltry” 1.9% in 2009, though Pfizer leads a container with $1.1 billion.
- BPA: Wisconsin is combined to a list of states banning BPA in baby bottles as well as cups.
- Nerd Link of a Week: You’ll only have to click to find out…
Happy Monday!
